外科手術用封止剤・接着剤の世界市場予測（～2021年）：天然、合成、フィブリン、コラーゲン、ゼラチン、シアノアクリル酸、アルブミン、人血...市場調査レポートについてご紹介

1 Introduction (Page No. – 27)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 30)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumption for the Study

3 Executive Summary (Page No. – 38)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 43)
4.1 Growth Potential of the Surgical Sealants Market
4.2 Asia-Pacific Surgical Sealants Market: By Product
4.3 Surgical Sealants Market: Geographic Growth Opportunities
4.4 Surgical Sealants Market: Regional Mix
4.5 Surgical Sealants Market: Developed vs Developing Countries

5 Market Overview (Page No. – 47)
5.1 Introduction
5.2 Market Dynamics
5.3 Key Market Drivers
5.3.1 Growing Need to Manage Blood Loss in Patients
5.3.2 Rising Number of Surgical Procedures Across the Globe
5.3.3 Greater Uptake of Technlogically Advanced Products
5.3.4 FDA and Ce Mark Approvals Driving the Adoption of Surgical Sealants and Adhesives
5.4 Key Market Restraints
5.4.1 Lack of Reimbursements for Surgical Sealants and Adhesives
5.4.2 High Costs and Extensive Clinical Data Requirements for Launching New Products
5.5 Key Market Opportunities
5.5.1 Improving Healthcare Systems in Emerging Markets
5.6 Key Challenges
5.6.1 Development of Novel Biomaterials With High Mechanical Properties and Adhesion Strength
5.6.2 Need for Skilled Personnel for the Effective Use of Surgical Sealants and Adhesives

6 Industry Insights (Page No. – 56)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Preference for Gelatin-Based Adhesives and Hydrogels in Surgical Procedures
6.2.2 Increasing Number of Acquisitions Driving Consolidation in the Market
6.2.3 Rising Prominence of Adhesive Dentistry
6.3 Porter’s Five Forces Analysis
6.3.1 Threats From New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Buyers
6.3.4 Intensity of Competitive Rivalry
6.4 Strategic Benchmarking
6.5 Regulatory Analysis
6.5.1 North America
6.5.1.1 U.S.
6.5.1.2 Canada
6.5.2 Europe
6.5.3 Asia-Pacific
6.5.3.1 Japan
6.5.3.2 China
6.5.3.3 India
6.6 Clinical Trial Assessment

7 Surgical Sealants Market, By Product (Page No. – 74)
7.1 Introduction
7.2 Natural/Biological Sealants and Adhesives
7.2.1 Natural/Biological Sealants and Adhesives, By Type
7.2.1.1 Polypeptide/Protein-Based Sealants and Adhesives
7.2.1.1.1 Fibrin Based
7.2.1.1.2 Collagen Based
7.2.1.1.3 Gelatin Based
7.2.1.1.4 Albumin Based
7.2.1.2 Polysaccharide Based Sealants and Adhesives
7.2.1.2.1 Chitosan Based
7.2.1.2.2 Other Polysaccharide Based
7.2.2 Natural/Biological Sealants and Adhesives, By Origin
7.2.2.1 Human Blood Based
7.2.2.2 Animal Based
7.3 Synthetic and Semisynthetic Sealants and Adhesives
7.3.1 Cyanoacrylates
7.3.2 Polyethylene Gylcol Based Hydrogel
7.3.3 Urethane-Based Adhesives
7.3.4 Other Synthetic Sealants and Adhesives

8 Surgical Sealants Market, By Indication (Page No. – 105)
8.1 Introduction
8.2 Surgical Hemostasis
8.3 Tissue Sealing
8.4 Tissue Engineering

9 Surgical Sealants Market, By Application (Page No. – 112)
9.1 Introduction
9.2 Central Nervous System (CNS) Surgeries
9.3 General Surgeries
9.4 Cardiovascular Surgeries
9.5 Orthopedic Surgeries
9.6 Cosmetic Surgeries
9.7 Ophthalmic Surgeries
9.8 Urological Surgeries
9.9 Pulmonary Surgeries
9.10 Other Applications

10 Surgical Sealants Market, By Geography (Page No. – 130)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.2 Middle East and Africa

11 Competitive Landscape (Page No. – 216)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Regulatory Approvals
11.3.2 Acquisitions
11.3.3 Expansions
11.3.4 Agreements, Partnerships, and Collaborations
11.3.5 Product Launches
11.3.6 Others

12 Company Profiles (Page No. – 226)
12.1 Introduction
12.2 Baxter International, Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM View
12.3 Johnson & Johnson (Ethicon, Inc.)
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments
12.3.4 MnM View
12.4 Medtronic PLC
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Cryolife, Inc.
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments
12.5.4 MnM View
12.6 C.R. Bard, Inc.
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Sanofi Group
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments
12.8 B. Braun Melsungen AG
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Developments
12.9 Cohera Medical, Inc.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments
12.10 Ocular Therapeutix, Inc.
12.10.1 Business Overview
12.10.2 Financials
12.10.3 Products Offered
12.10.4 Recent Developments
12.11 Vivostat A/S
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments
12.12 Sealantis Ltd.
12.12.1 Business Overview
12.12.2 Products Offered
12.12.3 Recent Developments

13 Appendix (Page No. – 252)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports